Record overview
Status and phase
Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Tallac Therapeutics
Condition: Advanced or Metastatic Solid Tumors
NCT05399654
A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal | long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.